23andme Holding Co Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

23andme Holding Co's inventory turnover ratio, the ratio that measures 23andme Holding Co's ability to manage its supply chain, sequentially decreased to 4.97 in the first quarter 2025, which does not come as a surprise, as the 23andme Holding Co continue to experience headwinds, which also impact its supply chain. 23andme Holding Co's average inventory processing period in the Jun 30 2025 quarter, has increased to 73 days, from 68 days, in the Mar 31 2025 quarter.

Within Healthcare sector 73 other companies have achieved higher inventory turnover ratio. While inventory turnover ranking remained unchanged in the First Quarter 2026 compared to previous quarter at no. 602.

ME Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is 23andme Holding Co Market Share?

What is Inventory Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Inventory Turnover▼

None ▼

Inventory Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

ME Inventory Turnover Ratio	(Jun 30 2025) I. Quarter	(Mar 31 2025) IV. Quarter	(Dec 31 2024) III. Quarter	(Sep 30 2024) II. Quarter	(Jun 30 2024) I. Quarter
Y / Y Inventory Growth	-9.02 %	24.81 %	36.65 %	-0.89 %	24.82 %
Y / Y Cost of Sales Growth	-42.11 %	-23.68 %	-16.67 %	-25 %	-36.67 %
Inventory Turnover Ratio (TTM)	4.97	5.35	6.18	7.07	7.54
ME's Total Ranking	# 602	# 602	# 314	# 509	# 401
Average inventory processing period	73	68	59	52	48
Seq. Inventory Growth	-13.76 %	-27.32 %	44.19 %	0.67 %	18.31 %
Seq. Cost of Sales Growth	-62.07 %	45 %	-4.76 %	10.53 %	-50 %

Inventory Turnover Ratio Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 18
Healthcare Sector	# 74
Overall Market	# 602

Inventory Turnover Ratio Statistics
High	Average	Low
13.9	9.6	4.97
(Mar 31 2023)		(Jun 30 2025)

ME Company Profile >> Back to ME Efficiency Comparisons >> Compare ME Inventory Turnover Ratio to its Competitors

Financial Statements
23andme Holding Co's Inventories	$ 13 Millions	Visit ME's Balance sheet
23andme Holding Co's Cost of Revenues TTM	$ 81 Millions	Visit ME's Income Statement
What are ME's Sales?		Visit ME's Sales by Segment

Other Inventory Turnover Ratios
23andme Holding Co's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Major Pharmaceutical Preparations Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
ME's Inventory Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for ME's Competitors
Inventory Turnover Ratio for ME's Suppliers
Inventory Turnover Ratio for ME's Customers

You may also want to know
ME's Sales Growth Rates	ME's Pe Price to earnings ratio	ME's Receivables Turnover Ratio	ME's Stock Quote
ME's Net Income Growth Rates	ME's Ps Price to Sales ratio	ME's Sales per Employee	ME's Asset Turnover Ratio
ME's Net Margin	ME's Pb Price to Book ratio	ME's Financial Strength Ratios	ME's Dividend Payout Ratio

Companies with similar Inventory Turnover Ratio for the quarter ending Jun 30 2025, within Healthcare Sector	Inventory Turnover Ratio	Cost of revenues at quarter ending Jun 30 2025	Inventories at quarter ending Jun 30 2025
Agape Atp Corporation	15.97	$ 0.718 Millions	$ 0 Millions
The Oncology Institute Inc	15.68	$ 189.091 Millions	$ 12 Millions
Precipio inc	14.70	$ 11.750 Millions	$ 1 Millions
Natera Inc	14.69	$ 727.695 Millions	$ 50 Millions
Rockwell Medical inc	13.80	$ 72.000 Millions	$ 5 Millions
Novavax inc	13.38	$ 126.728 Millions	$ 9 Millions
Irhythm Holdings Inc	12.81	$ 198.000 Millions	$ 15 Millions
Option Care Health Inc	11.74	$ 4,318.129 Millions	$ 368 Millions
Cryo cell International Inc	10.88	$ 7.604 Millions	$ 1 Millions
Neuronetics Inc	10.54	$ 48.000 Millions	$ 5 Millions
Scorpius Holdings inc	10.29	$ 2.010 Millions	$ 0 Millions
Lifemd Inc	10.29	$ 30.000 Millions	$ 3 Millions
Genedx Holdings Corp	10.26	$ 118.000 Millions	$ 12 Millions
Infusystem Holdings Inc	10.18	$ 63.584 Millions	$ 6 Millions
Aspira Women s Health inc	9.49	$ 2.727 Millions	$ 0 Millions
Semler Scientific inc	9.44	$ 3.933 Millions	$ 0 Millions
Nutriband Inc	9.23	$ 1.692 Millions	$ 0 Millions
Puma Biotechnology Inc	9.17	$ 65.875 Millions	$ 7 Millions
Invo Fertility Inc	9.04	$ 2.012 Millions	$ 0 Millions
Sotera Health Company	8.94	$ 500.000 Millions	$ 56 Millions
Myriad Genetics Inc	8.85	$ 245.000 Millions	$ 28 Millions
Neuraxis Inc	8.84	$ 0.521 Millions	$ 0 Millions
Castle Biosciences Inc	8.80	$ 65.801 Millions	$ 7 Millions
National Vision Holdings Inc	8.68	$ 780.491 Millions	$ 90 Millions
Harvard Apparatus Regenerative Technology Inc	8.66	$ 0.580 Millions	$ 0 Millions
Earth Science Tech Inc	8.27	$ 4.265 Millions	$ 1 Millions
Collegium Pharmaceutical Inc	8.18	$ 304.661 Millions	$ 37 Millions
Lantheus Holdings Inc	8.16	$ 551.000 Millions	$ 68 Millions
Cardiff Lexington Corporation	8.11	$ 4.382 Millions	$ 1 Millions
Opko Health Inc	7.99	$ 492.418 Millions	$ 62 Millions

Date modified: 2026-08-29T17:43:38+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.